Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1
Published January 31, 2024 · Recall initiated: January 12, 2024
Summary
FDA records drug Class II recall D-0258-2024, published January 31, 2024 and initiated January 12, 2024. Recalling firm: IntegraDose Compounding Services LLC; Status: Ongoing; Reported quantity: 281 syringes; Lot: Lot #: 20230921VAS-2, Exp. Date 03/19/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- IntegraDose Compounding Services LLC
- Distributor
- MN only
- Lot
- Lot #: 20230921VAS-2, Exp. Date 03/19/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650June 24, 2026
- FDAfentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose CompoundingMay 27, 2026
- FDAOxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose CompoundingOctober 22, 2025
- FDAfentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services,April 10, 2024
- FDABenzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by:January 31, 2024
- FDAFluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only,January 31, 2024
Questions about this recall
Was Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1 recalled?
Yes. FDA published recall D-0258-2024 on January 31, 2024. Reported hazard: Subpotent Drug
What should I do if I have this product?
Voluntary: Firm initiated · Letter